CRIS Current Research Information System

LUGARESI, ALESSANDRA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 15.544
NA - Nord America 12.627
EU - Europa 9.303
SA - Sud America 1.358
AF - Africa 531
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 6
Totale 39.394
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.406
VN - Vietnam 5.029
SG - Singapore 3.660
CN - Cina 3.428
GB - Regno Unito 2.559
IT - Italia 2.185
DE - Germania 1.537
HK - Hong Kong 1.086
BR - Brasile 1.013
FR - Francia 789
IN - India 731
RU - Federazione Russa 561
BD - Bangladesh 454
SE - Svezia 364
IE - Irlanda 271
KR - Corea 265
ZA - Sudafrica 260
JP - Giappone 248
NL - Olanda 196
EE - Estonia 185
FI - Finlandia 156
UA - Ucraina 136
AR - Argentina 129
ID - Indonesia 109
CA - Canada 101
TR - Turchia 76
TG - Togo 74
EC - Ecuador 72
AT - Austria 67
MX - Messico 65
PH - Filippine 63
IQ - Iraq 59
CI - Costa d'Avorio 53
CH - Svizzera 45
CO - Colombia 41
ES - Italia 41
PL - Polonia 38
IR - Iran 36
PK - Pakistan 35
JO - Giordania 34
TH - Thailandia 32
UZ - Uzbekistan 31
GR - Grecia 30
SA - Arabia Saudita 28
CL - Cile 27
BG - Bulgaria 24
PY - Paraguay 24
BE - Belgio 23
SC - Seychelles 21
VE - Venezuela 21
AU - Australia 20
EG - Egitto 20
MY - Malesia 20
KE - Kenya 16
MA - Marocco 16
HR - Croazia 15
NG - Nigeria 15
TW - Taiwan 15
DO - Repubblica Dominicana 14
DZ - Algeria 14
PE - Perù 14
AZ - Azerbaigian 13
KZ - Kazakistan 12
RO - Romania 12
JM - Giamaica 11
LB - Libano 11
UY - Uruguay 11
CZ - Repubblica Ceca 10
IL - Israele 10
NP - Nepal 10
TN - Tunisia 9
AE - Emirati Arabi Uniti 8
RS - Serbia 8
LT - Lituania 7
PS - Palestinian Territory 7
AL - Albania 6
BO - Bolivia 6
CR - Costa Rica 6
GA - Gabon 6
NI - Nicaragua 6
CY - Cipro 5
ET - Etiopia 5
GT - Guatemala 5
PT - Portogallo 5
BH - Bahrain 4
DK - Danimarca 4
GE - Georgia 4
NZ - Nuova Zelanda 4
OM - Oman 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
SY - Repubblica araba siriana 4
AM - Armenia 3
GH - Ghana 3
LV - Lettonia 3
MT - Malta 3
NO - Norvegia 3
SI - Slovenia 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
Totale 39.342
Salva come PNG Salva come JPEG
Città #
Singapore 2.379
Southend 2.335
Fairfield 1.402
Ho Chi Minh City 1.319
Ashburn 1.175
Hanoi 1.135
Hong Kong 1.056
Woodbridge 630
Seattle 605
Houston 599
Wilmington 598
Hefei 573
Beijing 538
Princeton 534
Ann Arbor 505
Cambridge 496
San Jose 482
Santa Clara 476
Dong Ket 438
Boardman 436
Lauterbourg 423
Chandler 352
Dublin 259
Nanjing 246
Bologna 243
Seoul 237
Council Bluffs 235
Westminster 234
Tokyo 229
Milan 198
Berlin 197
Padova 191
Los Angeles 175
Frankfurt am Main 154
Haiphong 150
Da Nang 141
Buffalo 139
Dallas 134
Redondo Beach 128
New York 121
Rome 114
Saint Petersburg 111
San Diego 102
Helsinki 101
Jinan 94
Biên Hòa 90
Medford 89
São Paulo 86
Quận Bình Thạnh 84
Shenyang 84
Ha Long 81
Dearborn 76
Lomé 74
Guangzhou 72
Hải Dương 72
Can Tho 71
Hebei 71
Bremen 69
Nanchang 68
Changsha 66
Nuremberg 65
Turin 63
Ninh Bình 62
Redmond 62
Bengaluru 61
Shanghai 59
Thái Nguyên 59
Tianjin 53
Abidjan 52
Moscow 52
Munich 51
Chicago 46
Des Moines 46
Florence 46
Jakarta 44
Zhengzhou 44
Falls Church 42
Vũng Tàu 42
Norwalk 41
Bắc Giang 40
Bắc Ninh 40
Rio de Janeiro 40
Jiaxing 37
Lappeenranta 37
Phoenix 37
Toronto 35
Hangzhou 34
Amman 33
London 33
Mexico City 33
Naples 33
Phủ Lý 33
Vinh 33
Quận Một 30
Xi'an 30
Vienna 28
Ningbo 27
Quận Phú Nhuận 27
San Francisco 27
Taizhou 27
Totale 25.256
Salva come PNG Salva come JPEG
Nome #
Machine-learning-based prediction of disability progression in multiple sclerosis: An observational, international, multi-center study 2.807
Persistence on Therapy and Propensity Matched Outcome Comparison of Two Subcutaneous Interferon Beta 1a Dosages for Multiple Sclerosis 486
Distonia faringea parossistica non dolorosa: un esordio atipico di sclerosi multipla. 446
Progression independent of relapse activity in relapsing multiple sclerosis: impact and relationship with secondary progression 246
Circadian Activity Rhythm in Early Relapsing-Remitting Multiple Sclerosis 236
Health-related quality of life in clinically isolated syndrome and risk of conversion to multiple sclerosis 225
The ND1 gene of complex I is a mutational hot spot for Leber's hereditary optic neuropathy. 216
Assessing subjective quality of life domains after multiple sclerosis diagnosis disclosure 215
Difference in safety and humoral response to mRNA SARS-CoV-2 vaccines in patients with autoimmune neurological disorders: the ANCOVAX study 210
A comparison of the brief international cognitive assessment for multiple sclerosis and the brief repeatable battery in multiple sclerosis patients 198
Assessing robustness of quantitative susceptibility-based MRI radiomic features in patients with multiple sclerosis 192
Effect of the disclosure of MS diagnosis on anxiety, mood and quality of life of patients: A prospective study 192
Teeth loss after teriflunomide treatment: Casual or causal? A short case series 190
Tetrahydrocannabinol/Cannabidiol Oromucosal Spray in Patients With Multiple Sclerosis: A Pilot Study on the Plasma Concentration-Effect Relationship 186
When 'good' is not good enough: a retrospective Rasch analysis study of the Berg Balance Scale for persons with Multiple Sclerosis 177
Frequency and characteristics of dysautonomic symptoms in multiple sclerosis: a cross-sectional double-center study with the validated Italian version of the Composite Autonomic Symptom Score-31 176
Multiparametric MRI dataset for susceptibility-based radiomic feature extraction and analysis 172
The use of immunosuppressant therapy for multiple sclerosis in Italy: A multicenter retroprospective study 172
eMSQOL-29: Prospective validation of the abbreviated, electronic version of MSQOL-54 171
A Pilot Study of 24-h Motor Activity Patterns in Multiple Sclerosis: Pre-Planned Follow-Up at 2 Years 171
Antibiotic Use and Risk of Multiple Sclerosis: A Nested Case-Control Study in Emilia-Romagna Region, Italy 169
Dissipation of Motor Sleep Inertia and Motor Wake Inertia in Early Relapsing–Remitting Multiple Sclerosis 168
The brief international cognitive assessment for multiple sclerosis (BICAMS): normative values with gender, age and education corrections in the Italian population. 166
The impact of the COVID-19 pandemic on people with neurological disorders: an urgent need to enhance the health care system's preparedness 164
Sleep-related disorders and their relationship with MRI findings in multiple sclerosis 158
Hypogammaglobulinemia and severe infections in Multiple Sclerosis patients on anti-CD20 agents: A multicentre study 156
Development of a short version of MSQOL-54 using factor analysis and item response theory 154
Decidere la maternità. Un ausilio per le donne con SM 152
Anxiety and depression in multiple sclerosis patients around diagnosis 151
Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis 150
BREMSO: A simple score to predict early the natural course of multiple sclerosis 148
Anti-inflammatory disease-modifying treatment and disability progression in primary progressive multiple sclerosis: a cohort study 148
Use of herbal remedies by multiple sclerosis patients: a nation-wide survey in Italy 147
Hematopoietic Stem Cell Transplantation in People With Active Secondary Progressive Multiple Sclerosis 146
Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis 146
An information aid for newly diagnosed multiple sclerosis patients improves disease knowledge and satisfaction with care. 144
Patient expression of emotions and neurologist responses in first multiple sclerosis consultations 142
Beyond disease: Happiness, goals, and meanings among persons with multiple sclerosis and their caregivers 141
Burden and resources in caregivers of people with multiple sclerosis: A qualitative study 140
Sapere Migliora : informazioni sulla SM per la persona neodiagnosticata 140
Progression is independent of relapse activity in early multiple sclerosis: a real-life cohort study 138
Active and non-active secondary progressive multiple sclerosis patients exhibit similar disability progression: results of an Italian MS registry study (ASPERA) 137
Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in rapidly evolving severe relapsing-remitting multiple sclerosis in the United Kingdom 136
Pregnancy and fetal outcomes after Glatiramer Acetate exposure in patients with multiple sclerosis: a prospective observational multicentric study 136
Construction of a resource for advance care planning in multiple sclerosis (ConCure-SM): Results of cognitive debriefing with users 135
Multiple sclerosis in Latin America: A different disease course severity? A collaborative study from the MSBase Registry 135
Redefining the Multiple Sclerosis Severity Score (MSSS): The effect of sex and onset phenotype 135
Advance Care Planning in Neurodegenerative Disorders: A Scoping Review 135
Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis 134
OXIDATIVE MODIFICATIONS OF CEREBRAL TRANSTHYRETIN ARE ASSOCIATED WITH MULTIPLE SCLEROSIS 133
The brief international cognitive assessment for multiple sclerosis (bicams): normative values in the Italian population. 132
The Multiple Sclerosis Knowledge Questionnaire: a self administered instrument for recently diagnosed patients 131
Disability accrual in primary and secondary progressive multiple sclerosis 130
The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry. 130
Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric study. 130
Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: the Italian multi-centre experience 130
Natalizumab treatment reduces L-selectin (CD62L) in CD4+ T cells 130
Comparative efficacy of switching to natalizumab in active multiple sclerosis 129
Decision-Making in Multiple Sclerosis Consultations in Italy: Third Observer and Patient Assessments 129
Patient-rated suitability of a novel electronic device for self-injection of subcutaneous interferon beta-1a in relapsing multiple sclerosis: an international, single-arm, multicentre, Phase IIIb study. 128
Home-based palliative approach for people with severe multiple sclerosis and their carers: Study protocol for a randomized controlled trial 128
Standardized Definition of Progression Independent of Relapse Activity (PIRA) in Relapsing-Remitting Multiple Sclerosis 127
Predictors of disability worsening in clinically isolated syndrome. 127
Risk of multiple sclerosis following clinically isolated syndrome: a 4-year prospective study. 127
A computational platform for MALDI-TOF mass spectrometry data: Application to serum and plasma samples 127
User appraisal of a booklet for advance care planning in multiple sclerosis: a multicenter, qualitative Italian study 126
Country, Sex, EDSS Change and Therapy Choice Independently Predict Treatment Discontinuation in Multiple Sclerosis and Clinically Isolated Syndrome. 126
Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial 125
Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis 124
The Italian multiple sclerosis register 124
Study protocol on advance care planning in multiple sclerosis (ConCure-SM): intervention construction and multicentre feasibility trial 123
Women and multiple sclerosis: From gender medicine to precision medicine 122
Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group. 122
The coexistence of well- and ill-being in persons with multiple sclerosis, their caregivers and health professionals. 122
Epidural analgesia and cesarean delivery in multiple sclerosis post-partum relapses: the Italian cohort study 122
Editorial: Aging in multiple sclerosis: from childhood to old age, in women and men 121
Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis 121
Evaluating dalfampridine for the treatment of relapsing-remitting multiple sclerosis: does it add to the treatment armamentarium? 121
Applying multidimensional computerized adaptive testing to the MSQOL-54: a simulation study 120
Explainable time-to-progression predictions in multiple sclerosis 120
Anti-JCV serostatus, index value and clinical features in patients affected by multiple sclerosis. 120
Illness Perception and Well-Being Among Persons with Multiple Sclerosis and Their Caregivers 120
F response in vascular and degenerative upper motor neuron lesions 120
Unmet needs of people with severe multiple sclerosis and their carers: qualitative findings for a home-based intervention. 119
Male Sex Is Independently Associated with Faster Disability Accumulation in Relapse-Onset MS but Not in Primary Progressive MS. 118
Clinical and therapeutic predictors of disease outcomes in AQP4-IgG+ neuromyelitis optica spectrum disorder 117
A comparison of the Brief International Cognitive Assessment for Multiple Sclerosis and a brief repeatable battery in multiple sclerosis patients. 116
Predictors of relapse and disability progression in MS patients who discontinue disease-modifying therapy 116
Lipidomic investigations for the characterization of circulating serum lipids in multiple sclerosis 115
Individualized quality of life of severely affected multiple sclerosis patients: practicability and value in comparison with standard inventories 115
Risk of secondary progressive multiple sclerosis: A longitudinal study 115
A comparison of the brief International cognitive assessment for multiple sclerosis and the brief repeatable battery in multiple sclerosis patients. 114
Conversion to secondary progressive multiple sclerosis: Patient awareness and needs. Results from an online survey in Italy and Germany 114
Cognitive dysfunction in patients with relapsing-remitting Multiple Sclerosis 112
IL-4 in vitro production is upregulated in Alzheimer's disease patients treated with acetylcholinesterase inhibitors 112
Cleavage of cystatin C is not associated with multiple sclerosis 112
Fingolimod after natalizumab and the risk of short-term relapse 112
Development and validation of a patient self-assessed questionnaire on satisfaction with communication of the multiple sclerosis diagnosis. 112
Multiple Sclerosis Severity Score (MSSS) improves the accuracy of individualized prediction in MS 111
Natalizumab therapy of multiple sclerosis: recommendations of the Multiple Sclerosis Study Group-Italian Neurological Society 111
Totale 17.543
Salva come PNG Salva come JPEG
Categoria #
all - tutte 119.341
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 119.341
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021848 0 0 0 0 0 0 0 0 0 0 0 848
2021/20223.919 314 350 207 199 448 238 119 372 146 219 517 790
2022/20233.063 357 456 152 395 139 161 166 165 502 170 221 179
2023/20241.130 91 157 86 85 98 101 63 112 55 69 94 119
2024/20255.937 206 1.062 613 452 792 397 361 166 152 168 310 1.258
2025/202616.329 3.410 1.521 1.592 1.190 1.139 671 1.315 612 2.313 1.017 977 572
Totale 40.542